Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Jun D Proto-Oncogene (JUND) (Middle Region) Peptide

JUND Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN5513395
  • Target See all JunD (JUND) products
    JunD (JUND) (Jun D Proto-Oncogene (JUND))
    Protein Region
    Middle Region
    Origin
    Human
    Source
    • 8
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB)
    Sequence
    PFPPPPPPGA LGPPRLAALK DEPQTVPDVP SFGESPPLSP IDMDTQERIK
    Characteristics
    This is a synthetic peptide designed for use in combination with anti- JUND Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Storage
    -20 °C
    Storage Comment
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    JunD (JUND) (Jun D Proto-Oncogene (JUND))
    Synonyms
    si:dkey-251j8.3 Peptide, AP-1 Peptide, Jund1 Peptide, JunD proto-oncogene, AP-1 transcription factor subunit Peptide, jun D proto-oncogene S homeolog Peptide, jun D proto-oncogene Peptide, jund Peptide, jund.S Peptide, JUND Peptide, Jund Peptide
    Background
    The protein encoded by this intronless gene is a member of the JUN family, and a functional component of the AP1 transcription factor complex. This protein has been proposed to protect cells from p53-dependent senescence and apoptosis. Alternative translation initiation site usage results in the production of different isoforms.

    Alias Symbols: AP-1

    Protein Size: 347
    Gene ID
    3727
    NCBI Accession
    NM_001286968, NP_001273897
    UniProt
    P17535
You are here:
Support